Literature DB >> 3522915

Current clinical management of hepatic problems in cystic fibrosis.

M S Tanner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3522915      PMCID： PMC1290126     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  59 in total

1.  Experiences with the triple-lumen single-balloon tube in massive upper gastrointestinal hemorrhage.

Authors:  M M NACHLAS
Journal:  Gastroenterology       Date:  1956-06       Impact factor: 22.682

2.  Correlation between the severity of esophageal varices in portal cirrhosis and their propensity toward hemorrhage.

Authors:  E D PALMER; I B BRICK
Journal:  Gastroenterology       Date:  1956-01       Impact factor: 22.682

3.  A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices.

Authors:  G W Johnston; H W Rodgers
Journal:  Br J Surg       Date:  1973-10       Impact factor: 6.939

4.  Doppler ultrasound probe for assessment of blood-flow in oesophageal varices.

Authors:  T McCormack; T Martin; R H Smallwood; P Robinson; L Walton; A G Johnson
Journal:  Lancet       Date:  1983-03-26       Impact factor: 79.321

Review 5.  Cystic fibrosis: its influence on the liver, biliary tree, and bile salt metabolism.

Authors:  J N Isenberg
Journal:  Semin Liver Dis       Date:  1982-11       Impact factor: 6.115

6.  Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient.

Authors:  A Viallet; D Marleau; M Huet; F Martin; A Farley; J P Villeneuve; P Lavoie
Journal:  Gastroenterology       Date:  1975-12       Impact factor: 22.682

7.  Cystic fibrosis: ultrasonographic findings in the pancreas and hepatobiliary system correlated with clinical data and pathology.

Authors:  N Graham; A R Manhire; R J Stead; W R Lees; M E Hodson; J C Batten
Journal:  Clin Radiol       Date:  1985-03       Impact factor: 2.350

8.  Fasting serum bile acid levels in relation to liver histopathology in cystic fibrosis.

Authors:  B Strandvik; K Samuelson
Journal:  Scand J Gastroenterol       Date:  1985-04       Impact factor: 2.423

9.  Endoscopic sclerotherapy using absolute alcohol.

Authors:  S K Sarin; G K Sachdeva; R Nanda; J C Vij; B S Anand
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

10.  Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage.

Authors:  J P Cello; J H Grendell; R A Crass; D D Trunkey; E E Cobb; D C Heilbron
Journal:  N Engl J Med       Date:  1984-12-20       Impact factor: 91.245
View more
  5 in total

1.  Liver and biliary problems in cystic fibrosis.

Authors:  M S Tanner
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

Review 2.  Rationale of modern dietary recommendations in cystic fibrosis.

Authors:  J M Littlewood; A MacDonald
Journal:  J R Soc Med       Date:  1987       Impact factor: 5.344

3.  The case for cystic fibrosis centres.

Authors:  T J David
Journal:  J R Soc Med       Date:  1987       Impact factor: 5.344

4.  Liver cirrhosis in cystic fibrosis.

Authors:  M D Stringer; J F Price; A P Mowat; E R Howard
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

5.  Serum glutathione S-transferase B1 activity as an index of liver function in cystic fibrosis.

Authors:  J M Rattenbury; C J Taylor; P K Heath; A F Howie; G J Beckett
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.